EXOSOMM News
6 articles
EXOSOMM in the Top 10 FoodTech World Cup Finalists 🥁
The article announces the Top 10 finalists of the FoodTech World Cup, highlighting innovative startups in the food for health sector. Among the finalists is Antithesis Foods Inc., a U.S.-based company that creates healthy snacks using patent-pending food science, funded by the National Science Foundation. Other finalists include companies from Singapore, Israel, Argentina, Sweden, Germany, and Brazil, each focusing on unique innovations such as fortified chocolates, bioactive supplements, sustainable fats, and more. The event is supported by notable partners like Givaudan and Nestlé Research & Development Lausanne. The competition showcases the global effort to enhance food technology and health through innovative solutions.
Milk extract could ease symptoms of Crohn's and colitis - ISRAEL21c
Exosomm, an Israeli biotech startup, is preparing for clinical trials of a natural supplement derived from cow milk to treat inflammatory bowel diseases like Crohn’s and colitis. The company has developed a method to extract exosomes from cow milk, which are similar to those found in human milk and have anti-inflammatory properties. These exosomes will be added to food products like yogurt and milkshake powders. The initial clinical trial will involve 30 healthy individuals and will be conducted in collaboration with Hadassah Medical Center. Exosomm has partnered with Tnuva, Israels largest food company, to extract exosomes from dairy milk processed in Tnuva plants. The company aims to make the product available by early 2025.
Product StagePartners
By leveraging its scientific research, EXOSOMM has devised a futuristic technique capable of extracting exosomes, which are naturally occurring particles found in maternal milk
Remilk, a Tel Aviv-based foodtech startup, is pioneering lab-grown dairy production using precision fermentation. This method allows for the creation of dairy proteins without traditional animal agriculture, offering a sustainable and ethical alternative. Remilk has received approval from the Israeli government and raised significant investment, including $120 million last year. The company is part of a broader movement in the Middle East to innovate in the dairy sector, with partnerships and investments from global giants like Danone and Unilever. The technology promises to reduce environmental impact and enhance food security in the region.
Product StageInvestmentPartners
Exosomm upcycles cheese by-products to derive a 'potent functional ingredient'
Exosomm, an Israeli foodtech start-up, has developed a method to isolate exosomes from upcycled whey, a byproduct of cheese production, to create a bioactive ingredient aimed at managing chronic metabolic disorders. The technology, developed at Hadassah University Medical Center, is now ready for commercial scaling. Exosomm collaborates with Ba’emek Tech for whey supply and infrastructure. The company has received $1 million in pre-seed investment from the Ofek-Galil incubator. Exosomms exosomes have shown promise in preclinical studies for reducing inflammation in IBD patients and improving glucose tolerance. The start-up is targeting the medical food space and plans further clinical research.
Product StagePartnersInvestment
Exosomm upcycles cheese by-products to derive a 'potent functional ingredient'
Exosomm, Ltd. is a company that specializes in utilizing exosomes, nano-sized particles found in breastmilk, for managing immune-related disorders in adults. The company has developed a technology to isolate exosomes from byproducts of the cheesemaking process. They have collaborated with Ba’emek Tech, a dairy food producer, to scale up production. Exosomm aims to target the medical food space and develop food formulas for consumers with special dietary requirements. The company has received $1 million in pre-seed investment from Ofek-Galil incubator. Their research has shown promising results in reducing inflammation and improving glucose tolerance in preclinical studies. The founders of Exosomm have extensive experience in the medical and food industries.
InvestmentExpand
מצמחי טבק לפיתוח בשר ועד לביצת מעבדה משודרגת: הפיתוחים שהגיעו לגמר תחרות הפודטק | כלכליסט
Six companies have reached the final stage of the Foodtech 2022 competition, showcasing their innovative developments in the food industry. BioBetter uses tobacco plants to produce growth factors for cultured meat. Eggmented Reality develops high-quality proteins for food manufacturers. Meala Foodtech is developing a technology that allows for healthier, better-textured, and more environmentally friendly plant-based meat substitutes. E-FISHient Protein is developing cultured fish meat. Watersight has invented an optical sensor for monitoring water quality. Exosomm operates in the field of genetic improvement.
InvestmentCustomersExpand
